To elucidate the mechanisms underlying PLA2G7 overexpression in bladder cancer, we initially examined genomic alterations, including copy number variations (CNVs) and methylation status of PLA2G7 within TCGA bladder cancer data. Here, PLA2G7 is linked to urinary bladder carcinoma.